J.P. Morgan Securities discloses dealing in Kangji Medical shares

On October 21, 2025, J.P. Morgan Securities PLC, identified as a Class (5) associate connected with the offeror in the privatization of Kangji Medical Holdings Limited, disclosed a dealing in the company’s shares. This disclosure was made pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers.

The transaction involved the issue of a derivative, with 2,500 reference securities relating to the derivative. The maturity date for this derivative is September 24, 2027. The reference price for the dealing was $9.0078, resulting in a total amount paid/received of $22,519.5000.

J.P. Morgan Securities PLC reported a resultant balance of 10,438,361. The dealings were made for its own account, and the entity is ultimately owned by JPMorgan Chase & Co.